Open Access  •  Multidisciplinary Research
Published by Peculiar 247 Group P247JMR on Zenodo
Blog

Research Ethics: What Every Author Should Confirm Before Submission

A practical guide listing the ethical confirmations authors should complete before submitting research: approvals, consent, conflicts, data, authorship and reporting transparency.

Research Ethics: What Every Author Should Confirm Before Submission

Answer up front: the essentials every author must confirm

Before you hit submit, confirm these core research ethics items: valid IRB or ethics committee approval (if needed), documented informed consent or justification for waiver, clear conflict-of-interest disclosures, accurate authorship attribution, a plagiarism check and a transparent data availability or materials statement. These cover the legal, participant-protection and integrity obligations most journals require.

Why these confirmations matter—and when exceptions apply

Ethics checks aren’t bureaucratic extras: they protect participants, preserve scientific trust and prevent delays or retractions. For human-subjects work you’ll usually need documented IRB (or equivalent) approval and signed informed consent. Retrospective analyses of fully anonymized public datasets can sometimes be exempt, but you must cite the exemption and the dataset’s access terms.

Animal studies require institutional animal care approval and adherence to reporting standards (e.g., ARRIVE). Laboratory or in vitro studies may still need biosafety approvals or clear statements if no ethical approval applies.

Practical checklist: documents and statements to gather

  • Ethics approval letters or protocol numbers for each site (IRB, REC, IACUC) and scope limits (dates, populations).
  • Informed consent forms or documented waiver rationale (who consented, how, language used, assent for minors).
  • Conflict of interest (COI) disclosures for all authors, including funding sources and material support.
  • Authorship contributions (who did conception, analysis, writing) and a signed authorship agreement if required.
  • Data availability statement: where raw data, code, and materials live or why they can’t be shared (privacy, proprietary constraints).
  • Plagiarism and image integrity check reports (similarity score, explanation for any overlap; originals for manipulated figures).
  • Clinical trial registration numbers before first patient enrollment and protocol-access details for trials.

How to document gray areas without slowing publication

If something is borderline—secondary analysis of restricted data, a justified data-sharing restriction, or a minor procedural deviation—document it concisely in your methods and in an author note. For example, state the exact data-use agreement clause preventing public release and offer a pathway for qualified researchers to access data under terms. Journals prefer transparent limitations over silence.

Handling multi-site and international work

Confirm which jurisdiction’s approval covers which participants. Some journals expect local ethics approval for each recruiting site; others accept a central IRB if you list local approvals or provide written justification. Translate or summarize non-English approvals and keep original certificates available on request.

Authorship and contribution: avoid common disputes

Decide authorship early, record contributions, and resolve disagreements before submission. Use a standard taxonomy (like CRediT) to list roles: conceptualization, methodology, analysis, writing – original draft, etc. Obtain written agreement from each author to the final manuscript and to the order of authorship; many journals require this during submission.

Conflict of interest and funding transparency

Disclose all financial and relevant non-financial relationships: funding bodies, employment, consultancies, stock ownership, or unpaid advisory roles that could reasonably bias interpretation. If a funder had a role in study design or manuscript drafting, state that clearly. When in doubt, disclose—the reader and editors can judge relevance.

Data, materials and reproducibility statements that reduce queries

Provide a specific data availability statement: repository name, persistent identifier (DOI), access conditions, or exactly why data cannot be shared. Share analysis code and protocols where possible; when not, offer to provide materials on reasonable request. Clear statements prevent reviewer requests that delay acceptance.

Quick operational tips before pressing submit

  • Attach ethics approval and consent templates as requested by the journal or note they’re available on request.
  • Run a final plagiarism/similarity check and keep the report; annotate any legitimate overlap (methods text, preprints).
  • Ensure all authors have ORCID iDs or that the submission system has their correct emails and affiliations.
  • Include trial registration numbers and protocol access links prominently in the abstract or first methods paragraph if applicable.
Pre-submission research ethics checklist
  • Confirm and attach ethics approval(s) or cite exemption rationale.
  • Include signed consent forms or explain waivers and assent procedures.
  • Prepare COI disclosures and funding statements for all authors.
  • Document authorship roles and secure written agreement from each author.
  • Create a precise data availability statement with repository details or restriction reasons.
  • Run and save plagiarism and image-integrity reports.
Practical takeaway

Before submission, stop and verify six areas: approvals, consent, conflicts, authorship, data transparency and originality. Transparency beats omission—journals will ask, and prompt documentation keeps your paper moving.

Frequently asked questions
Do I always need IRB approval for retrospective chart reviews?

Not always; many institutions allow exemptions for fully anonymized, minimal-risk chart reviews, but you must document the exemption from your IRB and state it in the manuscript.

How do I report a financial conflict that seems minor?

Disclose it. Even small payments or advisory roles should be listed; disclosure lets editors and readers assess relevance.

What if a co-author can’t be reached at submission time?

Troubleshoot through institutional emails and funder contacts; if unreachable, journals usually require documented efforts and may ask for a statement from the corresponding author.

Can I cite a preprint instead of a published protocol?

Yes, cite a preprint if that’s the only available protocol, but note its preprint status and provide DOI or persistent link.

How specific should my data availability statement be?

Be as specific as possible: repository name, accession numbers or exact access procedure, and any legal or ethical restrictions preventing sharing.